观察酚妥拉明与垂体后叶素治疗咯血48例的疗效

An Observation on Effect of Phentolamine and Pituitrin on 48 Cases of Hemoptysis

目的：探究对咯血患者采取酚妥拉明联合垂体后叶素进行治疗的临床疗效.方法：选取2013年5月-2014年5月期间到我院进行临床治疗的48例咯血患者作为研究对象,根据数字随机表法平均分成研究组与对照组.对照组患者采取单独的垂体后叶素进行止血治疗,而对于研究组患者则在对照组的基础上增加使用酚妥拉明进行临床止血,然后观察两组患者的临床治疗效果和不良反应的发生情况.结果：研究组总有效率91.67%显著高于对照组79.17%（P 〈0.05）;研究组不良反应总发生率12.50%明显低于对照组29.17%（P 〈0.05）.结论：对咯血患者采用酚妥拉明结合垂体后叶素进行治疗,既起到了协同止血的效果,提高了临床疗效,减同时也少了不良反应的发生,值得在临床上推广应用.

Objective:To investigate the effect of phentolamine combined pituitrin on the patients with hemoptysis.Methods:48 patients with hemoptysis received in our hospital during the period from May 2013 to May 2014 were selected as the research object,divide them into into research group and the control group according to random number table.The control group merely took pituitrin to carry out hemostasia ,while the research group were added with phentolamine on the basis of the treatment in control group.And t ob-serve the clinical treatment effect and the occurrence of adverse reactions in the 2 groups.Results:The overall effective rate was 91.67% in research group ,which is significantly higher than that in control group 79.17%(P <0.05);The overall occurrence rate of adverse reactions in research group was 12.50% significantly , which was lower than that in the control group 29.17% (P <0.05).Conclusion:Phentolamine and pituitrin has a cooperative hemostasia effect on patients with hemoptysis ,it woul help to improve clinical curative effect,reduce the occurrence of adverse reaction,it is worthy of clinical popularization and application.